ArticleCells2022

miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.

Patricia de la Cruz-Ojeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.